Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles

Background The significant progress in nanotechnology provides a wide spectrum of nanosized material for various applications, including tumor targeting and molecular imaging. The aim of this study was to evaluate multifunctional liposomal nanoparticles for targeting approaches and detection of tumors using different imaging modalities. The concept of dual-targeting was tested in vitro and in vivo using liposomes derivatized with an arginine-glycine-aspartic acid (RGD) peptide binding to αvβ3 integrin receptors and a substance P peptide binding to neurokinin-1 receptors. Methods For liposome preparation, lipids, polyethylene glycol building blocks, DTPA-derivatized lipids for radiolabeling, lipid-based RGD and substance P building blocks and imaging labels were combined in defined molar ratios. Liposomes were characterized by photon correlation spectroscopy and zeta potential measurements, and in vitro binding properties were tested using fluorescence microscopy. Standardized protocols for radiolabeling were developed to perform biodistribution and micro-single photon emission computed tomography/computed tomography (SPECT/CT) studies in nude mice bearing glioblastoma and/or melanoma tumor xenografts. Additionally, an initial magnetic resonance imaging study was performed. Results Liposomes were radiolabeled with high radiochemical yields. Fluorescence microscopy showed specific cellular interactions with RGD-liposomes and substance P-liposomes. Biodistribution and micro-SPECT/CT imaging of 111In-labeled liposomal nanoparticles revealed low tumor uptake, but in a preliminary magnetic resonance imaging study with a single-targeted RGD-liposome, uptake in the tumor xenografts could be visualized. Conclusion The present study shows the potential of liposomes as multifunctional targeted vehicles for imaging of tumors combining radioactive, fluorescent, and magnetic resonance signaling. Specific in vitro tumor targeting by fluorescence microscopy and radioactivity was achieved. However, biodistribution studies in an animal tumor model revealed only moderate tumor uptake and no additive effect using a dual-targeting approach.

[1]  K. Nicolay,et al.  Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements. , 2012, Contrast media & molecular imaging.

[2]  E. Ruoslahti,et al.  Arg-Gly-Asp: A versatile cell recognition signal , 1986, Cell.

[3]  Klaas Nicolay,et al.  Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[4]  F. Davis,et al.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. , 1977, The Journal of biological chemistry.

[5]  Peter S. Conti,et al.  MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  G. Wright,et al.  Rapid high‐resolution T1 mapping by variable flip angles: Accurate and precise measurements in the presence of radiofrequency field inhomogeneity , 2006, Magnetic resonance in medicine.

[7]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[8]  M. Bally,et al.  Controlling the Physical Behavior and Biological Performance of Liposome Formulations Through Use of Surface Grafted Poly(ethylene Glycol) , 2002, Bioscience reports.

[9]  Hideyoshi Harashima,et al.  Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake. , 2010, International journal of pharmaceutics.

[10]  M. Bednarski,et al.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.

[11]  Fan Wang,et al.  Specific Targeting of Human Integrin αvβ3 with 111In-Labeled Abegrin™ in Nude Mouse Models , 2011, Molecular Imaging and Biology.

[12]  R. Bellamkonda,et al.  A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[13]  J. Laissue,et al.  Substance‐P receptors in human primary neoplasms: Tumoral and vascular localization , 1995, International journal of cancer.

[14]  Wadih Arap,et al.  Probing the structural and molecular diversity of tumor vasculature. , 2002, Trends in molecular medicine.

[15]  W. Zhou,et al.  RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies. , 2011, European journal of radiology.

[16]  Hedvig Hricak,et al.  Molecular imaging for personalized cancer care , 2012, Molecular oncology.

[17]  M. Muñoz,et al.  The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer , 2012, TheScientificWorldJournal.

[18]  J. Krause,et al.  Human Astrocytoma Cells (U‐87 MG) Exhibit a Specific Substance P Binding Site with the Characteristics of an NK‐1 Receptor , 1996, Journal of neurochemistry.

[19]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[20]  C. Palma.  Tachykinins and their receptors in human malignancies. , 2006, Current drug targets.

[21]  R. Prassl,et al.  Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals , 2010, Journal of liposome research.

[22]  R. Prassl,et al.  Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles , 2012, International journal of nanomedicine.

[23]  Weibo Cai,et al.  Nanoplatforms for targeted molecular imaging in living subjects. , 2007, Small.

[24]  M. Kalia,et al.  Personalized oncology: recent advances and future challenges. , 2013, Metabolism: clinical and experimental.

[25]  Christina B. Cooley,et al.  Beyond Cell Penetrating Peptides: Designed Molecular Transporters. , 2012, Drug discovery today. Technologies.

[26]  D. Belnap,et al.  Formation of eLiposomes as a drug delivery vehicle. , 2012, Colloids and surfaces. B, Biointerfaces.

[27]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[28]  Klaas Nicolay,et al.  Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. , 2010, Nano letters.

[29]  N. Rofsky,et al.  Abdominal MR imaging with a volumetric interpolated breath-hold examination. , 1999, Radiology.

[30]  T. Allen,et al.  Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity. , 2005, Biochimica et biophysica acta.

[31]  D. Le Bihan,et al.  In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7 T , 2013, Magnetic resonance in medicine.

[32]  V. Torchilin,et al.  On the possibility of the unification of drug targeting systems. Studies with liposome transport to the mixtures of target antigens. , 1987, Biochemical pharmacology.

[33]  A. Rehemtulla,et al.  Molecular Imaging , 2009, Methods in Molecular Biology.

[34]  Ande Bao,et al.  Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging. , 2012, Bioconjugate chemistry.

[35]  Eric D. Pressly,et al.  Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. , 2011, ACS nano.

[36]  M. Muñoz,et al.  The NK-1 receptor: a new target in cancer therapy. , 2011, Current drug targets.

[37]  Zhaofei Liu,et al.  Dual-targeted molecular probes for cancer imaging. , 2010, Current pharmaceutical biotechnology.

[38]  K. Nicolay,et al.  Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis , 2010, Angiogenesis.

[39]  S. Neubauer,et al.  Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide , 2007, Arteriosclerosis, thrombosis, and vascular biology.